Big Gain For CytoMed Therapeutics Limited
Thu, Feb 05, 2026 at 07:41 PM
CytoMed Therapeutics Limited (GDTC:NASDAQ) rocketted at $1.08, representing a gain of 27.1%. On Thu, Feb 05, 2026, GDTC:NASDAQ touched a New 2-Week High of $1.08. The stock appeared on our News Catalysts scanner on Thu, Jan 29, 2026 at 10:34 AM in the 'BIOTECH' category. From Fri, Jan 23, 2026, the stock recorded 33.33% Up Days and 50.00% Green Days
The stock spiked on Wed, Oct 22, 2025 at $3.68 with a volume of 1M+.
About CytoMed Therapeutics Limited (GDTC:NASDAQ)
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human...
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 1333.33%
- F45 Training Holdings Inc. (FXLV:NYSE), 627.27%
- Lafayette Digital Acquisition Corp. I (ZKPW:NASDAQ), 260%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 43.36%
- UTime Limited (WTO:NASDAQ), 38.38%
- C3is Inc. (CISS:NASDAQ), 28.95%
- TruGolf Holdings, Inc. (TRUG:NASDAQ), 27.95%
- CytoMed Therapeutics Limited (GDTC:NASDAQ), 27.07%
- Estrella Immunopharma, Inc. (ESLA:NASDAQ), 25.71%
- Phibro Animal Health Corporation (PAHC:NASDAQ), 21.95%